Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
Abstract Several therapeutic options are currently available to treat excessive daytime sleepiness (EDS) in patients suffering from narcolepsy or obstructive sleep apnea. However, there are no comparisons between the various wake‐promoting agents in terms of mechanism of action, efficacy, or safety....
Main Authors: | Stéphane Krief, Isabelle Berrebi‐Bertrand, Isabelle Nagmar, Martin Giret, Simon Belliard, David Perrin, Marilyne Uguen, Philippe Robert, Jeanne‐Marie Lecomte, Jean‐Charles Schwartz, Olivier Finance, Xavier Ligneau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.855 |
Similar Items
-
Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority metaanalytical approach
by: Philippe Lehert, et al.
Published: (2020-07-01) -
Psychostimulants in the Treatment
of Depressive Disorders
by: Okan Ekinci, et al.
Published: (2015-09-01) -
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
by: Melinda Hersey, et al.
Published: (2021-05-01) -
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
by: Calik MW
Published: (2017-04-01) -
Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
by: Romigi A, et al.
Published: (2018-08-01)